A comprehensive view of Pediatrics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron’s Eylea injectable granted pediatric exclusivity by FDA for six months through May 17, 2024; Eylea treats wet age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy

Fennec Pharmaceuticals launches Pedmark sodium thiosulfate injection in US; drug reduces risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors

Decibel Therapeutics initiates Phase 1-2 clinical trial of DB-OTO gene therapy developed with Regeneron intended to provide hearing to patients with congenital hearing loss due to otoferlin deficiency; trial to involve pediatric patients

Children’s National Hospital selects Clearway Health as specialty pharmacy partner; Clearway Health to work to improve medication access, adherence, clinical outcomes for pediatric patients with complex chronic conditions

Johnson & Johnson Details Findings in Drug Development (The Role of Master Protocols In Pediatric Drug Development)

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count